The Discounted Cash Flow (DCF) valuation of Akoya Biosciences Inc (AKYA) is (23.64) USD. With the latest stock price at 1.05 USD, the upside of Akoya Biosciences Inc based on DCF is -2351.3%.
Based on the latest price of 1.05 USD and our DCF valuation, Akoya Biosciences Inc (AKYA) is a sell. selling AKYA stocks now will result in a potential gain of 2351.3%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 7.7% - 11.1% | 9.4% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (44.88) - (16.63) | (23.64) |
| Upside | -4374.5% - -1683.7% | -2351.3% |